Lymph Node Ratio as a Risk Factor for Early Recurrence in Older Patients with Stage II/III Gastric Cancer: A
Yun-Chen Tsai1, Hsin-Chen Lin2,3, Chiann-Yi Hsu4
1Department of Medical Education, Taichung Veterans General Hospital, Taichung 407219, Taiwan.
Journal of Clinical Medicine
|September 27, 2025
Summary
Early recurrence is common in older gastric cancer patients after surgery. A high lymph node ratio (LNR) greater than 0.17 significantly predicts increased risk of early cancer recurrence.
Area of Science:
- Oncology
- Geriatric Medicine
- Surgical Oncology
Background:
- Older adults with gastric cancer exhibit poorer prognoses compared to younger individuals.
- Early recurrence (within two years post-surgery) is linked to adverse outcomes, but its predictors are not well-defined.
- Identifying risk factors for early recurrence in elderly gastric cancer patients is crucial for improving treatment strategies.
Purpose of the Study:
- To identify clinicopathological predictors of early recurrence in older patients (≥65 years) with stage II/III gastric cancer.
- To analyze the patterns and risk factors associated with early gastric cancer recurrence in the elderly population.
Main Methods:
- Retrospective analysis of 237 elderly patients (≥65 years) with stage II/III gastric cancer who underwent curative surgery.
- Comparison of clinicopathological variables between patients with and without early recurrence.
- Logistic regression analysis to assess independent risk factors for early recurrence.
Main Results:
- Early recurrence was observed in 72 out of 103 (69.9%) recurrent cases among the elderly cohort.
- Distant metastasis was the most frequent recurrence pattern (59.7%), followed by peritoneal (45.8%) and locoregional (33.3%).
- A lymph node ratio (LNR) > 0.17 was identified as an independent predictor of early recurrence (OR, 5.30; 95% CI, 2.07-13.53; p < 0.001).
Conclusions:
- Early recurrence is a significant concern in older patients with stage II/III gastric cancer, predominantly manifesting as distant metastasis.
- An elevated lymph node ratio (LNR > 0.17) is a key predictor of increased early recurrence risk in this demographic.
- Adjuvant chemotherapy showed a non-significant trend towards risk reduction, warranting further investigation in prospective studies.


